Dimethyl fumarate modulates the immune environment and improves prognosis in the acute phase after ischemic stroke
Neuroimmunomodulation · 06.06.2024
DOI: 10.1159/000539589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroimmunomodulation, online erschienen am 06.06.2024. Verfasst von Chunrui Bo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China, bochunrui1993@163.com. Hauptthemen laut MEDLINE: Dimethyl Fumarate, Ischemic Stroke, Mice, Inbred C57BL. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Dimethyl fumarate (DMF) has shown potential for protection in various animal models of neurological diseases. However, the impact of DMF on changes in peripheral immune organs and the central nervous system (CNS) immune cell composition after ischemic stroke remains unclear.
Methods
Eight-week-old C57BL/6J mice with photothrombosis (PT) ischemia and patients with acute ischemic stroke (AIS) were treated with DMF. TTC staining, flow cytometry, and immunofluorescence staining were used to evaluate the infarct volume and changes in immune cells in the periphery and the CNS.
Results
DMF reduced the infarct volume on Day 1 after PT. DMF reduced the percentages of peripheral immune cells, such as neutrophils, dendritic cells, macrophages and monocytes, on Day 1, followed by NK cells on Day 3 and B cells on Day 7 after PT. In the CNS, DMF significantly reduced the percentage of monocytes in the brain on Day 3 after PT. In addition, DMF increased the number of microglia in the peri-infarct area and reduced the number of neurons in the peri-infarct area in the acute and subacute phases after PT. In AIS patients, B cells decreased in patients receiving alteplase in combination with DMF.
Conclusion
DMF can change the immune environment of the periphery and the CNS, reduce infarct volume in the acute phase, promote the recruitment of microglia and preserve neurons in the peri-infarct area after ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China, bochunrui1993@163.com.
- Department of Neurology, XuanWu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China, bochunrui1993@163.com.
- Department of Radiology, XuanWu Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, XuanWu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China.
- Beijing Municipal Geriatric Medical Research Center, Beijing, China.
- Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Zitieren
APA
Bo, C., Li, J., Wang, J., Zhang, Y., Wu, T., Wang, M., Hou, S., Liang, Y., Zhang, X., Zhao, S., Zhang, H., Wang, J., Wang, L., & Zhong, L. (2024). Dimethyl fumarate modulates the immune environment and improves prognosis in the acute phase after ischemic stroke. Neuroimmunomodulation. https://doi.org/10.1159/000539589
Vancouver
Bo C, Li J, Wang J, Zhang Y, Wu T, Wang M, et al. Dimethyl fumarate modulates the immune environment and improves prognosis in the acute phase after ischemic stroke. Neuroimmunomodulation. 2024. doi:10.1159/000539589
BibTeX
@article{Bo2024,
author = {Bo, Chunrui and Li, Jingkai and Wang, Junjie and Zhang, Yaxin and Wu, Tao and Wang, Mingyang and Hou, Shiyue and Liang, Yan and Zhang, Xiyue and Zhao, Shufang and Zhang, Huixue and Wang, Jianjian and Wang, Lihua and Zhong, Lianmei},
title = {Dimethyl fumarate modulates the immune environment and improves prognosis in the acute phase after ischemic stroke},
journal = {Neuroimmunomodulation},
year = {2024},
doi = {10.1159/000539589}
}
EUVIMED